Related Experiment Video
Updated: Mar 20, 2026

Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
Verworven Hypofibrinogenemie
1a Rijksuniversiteit Gent, Dienst voor Inwendige Ziekten, Akademisch Ziekenhuis, De Pintelaan 135, 9000 Gent, België.
Abstract:
The pathogenesis of acquired hypofibrinogenemia has been investigated in 52 cases by several blood coagulation parameters and by clinical and pathological findings. Disseminated intravascular coagulation, fibrinolysis, deficiency of synthesis and combinations of decreased synthesis with disseminated intravascular coagulation or fibrinolysis were found. The pathogenesis of acquired hypofibrinogenemia and its treatment are discussed.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

